It is Time to “Buy” Humana Inc (NYSE:HUM), Goldman Sachs Says. Stock May Be Worth $305.0

April 23, 2018 - By Louis Casey

Humana Inc. (NYSE:HUM) Logo

Investors sentiment decreased to 1.05 in Q4 2017. Its down 0.16, from 1.21 in 2017Q3. It worsened, as 40 investors sold Humana Inc. shares while 209 reduced holdings. 69 funds opened positions while 193 raised stakes. 125.53 million shares or 4.46% less from 131.39 million shares in 2017Q3 were reported.

Profund Lc reported 4,886 shares. 1.30M were accumulated by Tiaa Cref Investment Management Ltd Liability Corporation. Hl Fincl Ser Lc has 11,205 shares for 0.05% of their portfolio. X Mgmt Ltd reported 0.02% of its portfolio in Humana Inc. (NYSE:HUM). Madison Holdings Incorporated accumulated 49,075 shares or 0.21% of the stock. Credit Suisse Ag holds 0.05% or 228,221 shares. Psagot Investment House Ltd, Israel-based fund reported 3,000 shares. Shine Inv Advisory Services Inc accumulated 290 shares. Norinchukin Commercial Bank The reported 13,973 shares or 0.06% of all its holdings. York Capital Management Global Advsrs Lc has 134,260 shares. 1,191 were accumulated by Shelton Cap Mgmt. Raymond James Tru Na holds 0.01% or 898 shares in its portfolio. Baker Ellis Asset Mgmt Lc has 850 shares. Schroder Mngmt Grp reported 0.04% of its portfolio in Humana Inc. (NYSE:HUM). Fjarde Ap has invested 0.15% in Humana Inc. (NYSE:HUM).

Since December 15, 2017, it had 0 buys, and 10 selling transactions for $20.82 million activity. Zipperle Cynthia H sold 1,196 shares worth $326,899. Shares for $4.45M were sold by Huval Timothy S.. The insider Christopher M Todoroff sold 16,389 shares worth $4.48 million. LeClaire Brian P. had sold 12,719 shares worth $3.49M. The insider Fleming William Kevin sold $295,450. BILNEY JODY L sold $801,477 worth of Humana Inc. (NYSE:HUM) on Saturday, February 24.

Why Has Goldman Sachs Given Humana Inc (NYSE:HUM) a $305.0 Price Target

In a report revealed to clients today, Goldman Sachs analysts has started Humana Inc (NYSE:HUM) coverage with “Buy” rating, and a $305.0 TP.

Investors sentiment decreased to 1.05 in Q4 2017. Its down 0.16, from 1.21 in 2017Q3. It worsened, as 40 investors sold Humana Inc. shares while 209 reduced holdings. 69 funds opened positions while 193 raised stakes. 125.53 million shares or 4.46% less from 131.39 million shares in 2017Q3 were reported.

Profund Lc reported 4,886 shares. 1.30M were accumulated by Tiaa Cref Investment Management Ltd Liability Corporation. Hl Fincl Ser Lc has 11,205 shares for 0.05% of their portfolio. X Mgmt Ltd reported 0.02% of its portfolio in Humana Inc. (NYSE:HUM). Madison Holdings Incorporated accumulated 49,075 shares or 0.21% of the stock. Credit Suisse Ag holds 0.05% or 228,221 shares. Psagot Investment House Ltd, Israel-based fund reported 3,000 shares. Shine Inv Advisory Services Inc accumulated 290 shares. Norinchukin Commercial Bank The reported 13,973 shares or 0.06% of all its holdings. York Capital Management Global Advsrs Lc has 134,260 shares. 1,191 were accumulated by Shelton Cap Mgmt. Raymond James Tru Na holds 0.01% or 898 shares in its portfolio. Baker Ellis Asset Mgmt Lc has 850 shares. Schroder Mngmt Grp reported 0.04% of its portfolio in Humana Inc. (NYSE:HUM). Fjarde Ap has invested 0.15% in Humana Inc. (NYSE:HUM).

Since December 15, 2017, it had 0 buys, and 10 selling transactions for $20.82 million activity. Zipperle Cynthia H sold 1,196 shares worth $326,899. Shares for $4.45M were sold by Huval Timothy S.. The insider Christopher M Todoroff sold 16,389 shares worth $4.48 million. LeClaire Brian P. had sold 12,719 shares worth $3.49M. The insider Fleming William Kevin sold $295,450. BILNEY JODY L sold $801,477 worth of Humana Inc. (NYSE:HUM) on Saturday, February 24.

Humana Inc. (NYSE:HUM) Ratings Coverage

Among 13 analysts covering Humana Inc (NYSE:HUM), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Humana Inc has $35600 highest and $230.0 lowest target. $292.77’s average target is -0.70% below currents $294.83 stock price. Humana Inc had 23 analyst reports since November 3, 2017 according to SRatingsIntel. The company was maintained on Friday, November 10 by Credit Suisse. The stock of Humana Inc. (NYSE:HUM) has “Hold” rating given on Wednesday, November 8 by Cantor Fitzgerald. Cowen & Co maintained Humana Inc. (NYSE:HUM) rating on Monday, January 29. Cowen & Co has “Buy” rating and $330.0 target. The rating was maintained by Piper Jaffray with “Buy” on Tuesday, April 3. The firm has “Hold” rating given on Wednesday, February 7 by Cantor Fitzgerald. The rating was upgraded by Credit Suisse on Thursday, February 8 to “Outperform”. The firm has “Hold” rating given on Friday, March 30 by Cantor Fitzgerald. The firm has “Hold” rating by RBC Capital Markets given on Thursday, February 8. The rating was maintained by Morgan Stanley on Thursday, November 9 with “Overweight”. The rating was maintained by Cantor Fitzgerald on Monday, December 18 with “Hold”.

The stock increased 0.24% or $0.71 during the last trading session, reaching $294.83. About 109,239 shares traded. Humana Inc. (NYSE:HUM) has risen 31.54% since April 23, 2017 and is uptrending. It has outperformed by 19.99% the S&P500.

Analysts await Humana Inc. (NYSE:HUM) to report earnings on May, 2 before the open. They expect $3.21 EPS, up 16.73 % or $0.46 from last year’s $2.75 per share. HUM’s profit will be $443.26M for 22.96 P/E if the $3.21 EPS becomes a reality. After $2.06 actual EPS reported by Humana Inc. for the previous quarter, Wall Street now forecasts 55.83 % EPS growth.

Humana Inc., together with its subsidiaries, operates as a health and well-being firm in the United States. The company has market cap of $40.71 billion. The firm operates through three divisions: Retail, Group, and Healthcare Services. It has a 17.54 P/E ratio. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: